IP Library Granted Patent US 11,590,256
Granted Patent B2
US 11,590,256 · App. 16/759,220 · Granted Feb 28, 2023

Medical material produced using collagen and method for producing same

Inventors: Jin Sub Kim (Seoul, KR); Ji Chul Yoo (Namyangju-si, KR); Dong Sam Suh (Seoul, KR); Cheong Ho Chang (Seoul, KR)
Assignee: CELLONTECH CO., LTD.
A61L17/08A61L27/24D01D5/0015D10B2211/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,590,256
App. No.
16/759,220
Granted
Feb 28, 2023
Kind
B2
Abstract

Disclosed is a medical material manufactured using collagen and a method of manufacturing the same. The method includes (1) preparing collagen using distilled water as a solvent, (2) filling a syringe with the prepared collagen and then spinning the collagen through a syringe needle, (3) immediately immersing the spun collagen in a cross-linking solution, which is a mixture including therein a hyperosmotic agent and a cross-linking agent mixed with each other, (4) removing and then washing the collagen after cross-linking is completed, and (5) removing and then drying the collagen after the washing is completed. When the collagen is spun and processed into the form of a thread and the spun thread is then cross-linked, the cross-linked collagen thread has increased strength compared to before cross-linking, and the shape thereof is retained in an aqueous solution.

Claims (25)

1. A method of manufacturing a medical material using a collagen, comprising:

(1) preparing the collagen using distilled water as a solvent;

(2) filling a syringe with the prepared collagen and then spinning the collagen through a syringe needle;

(3) immediately immersing or exposing the spun collagen in or to a cross-linking solution, which is a mixture including therein a hyperosmotic agent and a cross-linking agent mixed with each other;

(4) removing and then washing the collagen after cross-linking is completed; and

(5) removing and then drying the collagen after the washing is completed,

wherein:

the hyperosmotic agent is glycerol and the cross-linking agent is glutaraldehyde, and a ratio of the glycerol and the glutaraldehyde for manufacturing the cross-linking solution is set so that the glutaraldehyde is included in an amount of 2% (v/v) based on the glycerol as the solvent.

2. A method of manufacturing a medical material using a collagen, comprising:

preparing the collagen using distilled water as a solvent;

immediately exposing the collagen to a cross-linking solution, which is a mixture including therein a hyperosmotic agent and a cross-linking agent mixed with each other; and

drying the collagen,

wherein:

the hyperosmotic agent is glycerol and the cross-linking agent is glutaraldehyde, and a ratio of the glycerol and the glutaraldehyde for manufacturing the cross-linking solution is set so that the glutaraldehyde is included in an amount of 2% (v/v) based on the glycerol as the solvent.

3. The method of claim 1 , wherein the collagen is included at a concentration of 1 to 15(%, w/v).

4. The method of claim 1 , wherein the spinning of step (2) is performed so that the collagen is spun into a thread and the spun thread has a thickness of 100 nm to 10 mm.

5. The method of claim 1 , wherein a cross-linking time is 1 minute to 48 hours.

6. The method of claim 1 , wherein the washing of step (4) includes exposure to any one selected from among PBS (phosphate-buffered saline), methanol, ethanol, distilled water, acetone, distilled water, and a physiological saline solution.

7. The method of claim 1 , wherein the drying is performed using any one selected from among freeze-drying, dry-heat drying, and natural drying.

8. The method of claim 1 , wherein the collagen is used as any one selected from among medical threads, medical films, suture threads, dental materials, supports, tissue replacement materials, tissue-restorative materials, adhesion barriers, hemostatic materials, drug delivery carriers, and stiffeners.

9. A medical material manufactured using a collagen according to the manufacturing method of claim 1 .

10. The method of claim 2 , wherein the collagen is included at a concentration of 1 to 15(%, w/v).

11. The method of claim 2 , wherein a cross-linking time is 1 minute to 48 hours.

12. The method of claim 2 , wherein the drying is performed using any one selected from among freeze-drying, dry-heat drying, and natural drying.

13. The method of claim 2 , wherein the collagen is used as any one selected from among medical threads, medical films, suture threads, dental materials, supports, tissue replacement materials, tissue-restorative materials, adhesion barriers, hemostatic materials, drug delivery carriers, and stiffeners.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2023
From: SEWON E&C CO., LTD.
To: CELLONTECH CO., LTD.
Reel/Frame 062401/0614 →
CHANGE OF NAME Recorded Jan 10, 2023
From: SEWONCELLONTECH CO., LTD.
To: SEWON E&C CO., LTD.
Reel/Frame 062338/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2020
From: KIM, JIN SUB; YOO, JI CHUL; SUH, DONG SAM; CHANG, CHEONG HO
To: SEWONCELLONTECH CO., LTD.
Reel/Frame 052492/0369 →
Priority Claims (1)
KR 10-2017-0146201 · Nov 3, 2017 · national
Continuity (1)
Related Publication 20200316247A1 · Oct 8, 2020